ARDX - ア―デリックス (Ardelyx Inc.)

ARDXのニュース

   FDA flags deficiencies in Ardelyx''s kidney disease treatment NDA  2021/07/19 20:08:37 Seeking Alpha
   Ardelyx Provides Regulatory Update on New Drug Application for Tenapanor for the Control of Serum Phosphorus in Adult Patients with CKD on Dialysis  2021/07/19 20:01:00 Yahoo Finance
Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company focused on the discovery, development, and commercialization of innovative first-in-class medicines to improve treatment for people with kidney and cardiorenal diseases, today announced that it received a letter from the U.S. Food and Drug Administration (the "FDA") on July 13, 2021, stating that, as part of its ongoing review of the company''s New Drug Application ("NDA") for the control of serum phosphorus in adult patients with chronic
   Ardelyx ($ARDX $NASDAQ) Analyst Coverage Initiated | Live Trading News  2021/07/05 15:05:25 Live Trading News
Prices are vulnerable to a correction towards 7.26, BUY THE DIPThe projected upper bound is: 18.66.The projected lower bound is: 7.11..
   ArdCoin (ARDX) is now available on UniSwap | NewsBTC  2021/06/22 18:58:39 NEWSBTC
Ulaanbaatar, Mongolia, 2021/06/18 - Mongolias first and only blockchain-based loyalty reward program ArdCoin is turning a new page in its history as it lists
   Ardelyx Announces Presentations at ERA-EDTA Virtual Congress 2021  2021/06/07 12:00:00 PR Newswire
FREMONT, Calif. and WALTHAM, June 7, 2021 /PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company focused on developing innovative first-in-class medicines to improve treatment for people with kidney and cardiorenal diseases, today announced two presentations
   42 Biggest Movers From Yesterday  2021/04/16 10:07:11 Benzinga
Gainers Esports Technologies, Inc. (NASDAQ: EBET ) shares jumped 507% to settle at $36.42 on Thursday. agilon health, inc. (NYSE: AGL ) gained 34.8% to close at $31.00 after the company priced its IPO at $23 a share. Wilhelmina International, Inc. (NASDAQ: WHLM ) shares climbed 29.8% to close at $10.80 on Thursday after gaining 14% on Wednesday. The company's 13D filing recently showed that Modell's Sporting Goods had reported a stake of 18.4% in the company. Kaspien Holdings Inc. (NASDAQ: KSPN ) gained 19.4% to close at $26.91 following Q4 results. Karat Packaging Inc. (NASDAQ: KRT ) climbed 16% to close at $18.56 after the company priced its IPO at $16 per share. PLBY Group, Inc. (NASDAQ: PLBY ) jumped 15.8% to close at $42.58. Elite Education Group International Limited (NASDAQ: EEIQ ) shares jumped 14.2% to close at $6.60. Ballantyne Strong, Inc (NYSE: BTN ) gained 13.8% to close at $4.61. Eton Pharmaceuticals, Inc. (NASDAQ: ETON ) rose 13.1% to settle at $8.56. Weingarten Realty Investors (NYSE: WRI ) gained 12.6% to close at $30.77 after the company announced a strategic merger agreement with Kimco Realty.
   Analyzing Ardelyx (NASDAQ:ARDX) and Rigel Pharmaceuticals (NASDAQ:RIGL)  2021/03/14 06:01:09 Modern Readers
Ardelyx (NASDAQ:ARDX) and Rigel Pharmaceuticals (NASDAQ:RIGL) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, dividends, risk, profitability, institutional ownership, valuation and analyst recommendations. Analyst Ratings This is a breakdown of recent ratings and target prices for Ardelyx and Rigel […]
   Ardelyx (NASDAQ:ARDX) Posts Quarterly Earnings Results, Misses Expectations By $0.06 EPS  2021/03/11 10:12:41 Transcript Daily
Ardelyx (NASDAQ:ARDX) announced its quarterly earnings data on Sunday. The biopharmaceutical company reported ($0.32) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.26) by ($0.06), MarketWatch Earnings reports. Ardelyx had a negative net margin of 1,063.74% and a negative return on equity of 53.93%. Shares of ARDX opened at $6.26 on Tuesday. […]
   Ardelyx Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Highlights  2021/03/08 13:00:00 PR Newswire
FREMONT, Calif. and WALTHAM, Mass., March 8, 2021 /PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company focused on developing innovative first-in-class medicines to improve treatment for people with kidney and cardiorenal diseases, today reported business highlights…
   Ardelyx Is it time to Buy before this week’s earning report Stock market Insights & financial analysis  2021/03/04 22:07:00 Stock Market Daily
Ardelyx announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by…
   Analyzing Ardelyx (NASDAQ:ARDX) and Rigel Pharmaceuticals (NASDAQ:RIGL)  2021/03/14 06:01:09 Modern Readers
Ardelyx (NASDAQ:ARDX) and Rigel Pharmaceuticals (NASDAQ:RIGL) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, dividends, risk, profitability, institutional ownership, valuation and analyst recommendations. Analyst Ratings This is a breakdown of recent ratings and target prices for Ardelyx and Rigel […]
   Ardelyx (NASDAQ:ARDX) Posts Quarterly Earnings Results, Misses Expectations By $0.06 EPS  2021/03/11 10:12:41 Transcript Daily
Ardelyx (NASDAQ:ARDX) announced its quarterly earnings data on Sunday. The biopharmaceutical company reported ($0.32) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.26) by ($0.06), MarketWatch Earnings reports. Ardelyx had a negative net margin of 1,063.74% and a negative return on equity of 53.93%. Shares of ARDX opened at $6.26 on Tuesday. […]
   Ardelyx Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Highlights  2021/03/08 13:00:00 PR Newswire
FREMONT, Calif. and WALTHAM, Mass., March 8, 2021 /PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company focused on developing innovative first-in-class medicines to improve treatment for people with kidney and cardiorenal diseases, today reported business highlights…
   Ardelyx Is it time to Buy before this week’s earning report Stock market Insights & financial analysis  2021/03/04 22:07:00 Stock Market Daily
Ardelyx announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by…
   Ardelyx (ARDX) May Report Negative Earnings: Know the Trend Ahead of Q4 Release | Investing.com  2021/02/26 18:20:06 Investing.com
Stocks Analysis by Zacks Investment Research covering: Ardelyx Inc. Read Zacks Investment Research's latest article on Investing.com

calendar